Hidden Heart Damage in Hyperthyroidism Revealed by Advanced MRI Mapping

An overactive thyroid is famous for making the heart race, but a new study suggests the damage may run deeper than a fast pulse. Researchers in Shanghai report that patients with hyperthyroidism who show clinical signs of cardiac involvement carry measurable changes in the very fabric of their heart muscle — changes invisible on standard heart scans but detectable with a specialized magnetic resonance technique called native T1 mapping. The findings, published in BMC Medical Imaging, offer some of the clearest imaging evidence yet that thyroid excess can alter myocardial tissue itself, potentially bridging a long-standing gap between thyroid disease and thyroid-related cardiomyopathy.

The research team, led by Yi Zhang and Xiaoyun Feng of Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, together with colleagues including corresponding authors Han Wang and Lei Zhang, set out to answer a deceptively simple question: when hyperthyroid patients complain of cardiac symptoms, show abnormal electrocardiograms, or display elevated cardiac biomarkers, is something actually changing inside the heart muscle? Hyperthyroidism has long been associated with increased cardiovascular risk and heart failure, yet a definite, demonstrable link between the hormonal state and cardiomyopathy has remained elusive in the clinical literature. Conventional measures of heart function often look reassuringly normal in these patients, leaving clinicians without an objective marker of early tissue injury.

To probe that question, the investigators conducted a single-center retrospective study comparing 41 hyperthyroid patients who had undergone clinically indicated cardiac magnetic resonance examinations with 31 healthy volunteers serving as controls. Crucially, the patients were not scanned on a whim: each had suspected cardiac involvement, defined by cardiac symptoms, electrocardiographic abnormalities, or elevated cardiac biomarkers such as type B natriuretic peptide or creatine kinase-MB. All participants underwent standardized CMR scanning, allowing the team to compare myocardial tissue characteristics, chamber volumes, mass, and function across the two groups using identical protocols.

The centerpiece of the study was multiparametric CMR, a suite of advanced magnetic resonance techniques that go far beyond the anatomical snapshots of echocardiography. Native T1 mapping measures the intrinsic relaxation time of hydrogen protons in heart tissue without contrast agents; because T1 values shift when the myocardial composition changes — whether through fibrosis, edema, or expansion of the space between cells — the technique acts as a molecular-scale biopsy of the living heart. The researchers also measured T2 values, which are sensitive to water content and inflammation, and calculated the extracellular volume fraction, or ECV, which estimates the proportion of the myocardium occupied by space outside cells, a recognized surrogate for diffuse fibrosis. Feature-tracking analysis of cine images yielded global longitudinal, circumferential, and radial strain, quantifying how much the heart muscle deforms with each beat.

The results were striking in their specificity. Hyperthyroid patients with suspected cardiac involvement had significantly higher myocardial native T1 values than controls — 1301.8 plus or minus 38.5 milliseconds versus 1270.0 plus or minus 19.6 milliseconds, a difference that was highly significant statistically. Because elevated heart rate, age, sex, and body mass index can all influence T1 measurements, the team re-ran the analysis with statistical adjustment for these confounders. The difference persisted: an adjusted difference of 20.89 milliseconds, with a 95 percent confidence interval of 3.08 to 38.71 and a P value of 0.022. In other words, the tissue-level signal was not an artifact of faster hearts or different body compositions — it reflected a genuine alteration in the myocardium itself.

Equally informative was what did not change. The researchers found no intergroup differences in left ventricular T2 values, global myocardial strain, left ventricular mass, or left ventricular ejection fraction. That pattern matters. T2 remained normal, arguing against overt myocardial edema or active inflammation, and strain and ejection fraction remained preserved, meaning the hearts were still pumping effectively and deforming normally by conventional metrics. Yet native T1 — the most sensitive indicator of subtle tissue remodeling — had already shifted. The study thus captures cardiac involvement at a stage where standard functional measures are still silent, a window that could prove decisive for early intervention.

The team also explored how the tissue changes relate to the hormonal storm driving them. In exploratory correlation analyses within the hyperthyroid group, the extracellular volume fraction showed a positive correlation with free triiodothyronine (FT3, r = 0.445, 95 percent CI 0.142 to 0.672, P = 0.006) and with total triiodothyronine (TT3, r = 0.363, 95 percent CI 0.044 to 0.615, P = 0.027). Triiodothyronine, or T3, is the biologically active thyroid hormone that drives cellular metabolism, and its excess is known to promote tachycardia, increased cardiac output, and structural remodeling in animal models. The correlation suggests that the greater the hormone excess, the more the extracellular compartment of the heart muscle expands — a dose-response relationship that strengthens the case for a causal link.

That said, the authors were careful about the robustness of this hormonal association. After adjustment for hematocrit, age, heart rate, and body mass index, the correlation with FT3 remained statistically significant (r = 0.357, 95 percent CI 0.037 to 0.610, P = 0.030), but the association with TT3 was attenuated and no longer reached significance (r = 0.304, 95 percent CI -0.023 to 0.571, P = 0.068). Hematocrit adjustment is particularly important for ECV measurements, since the technique relies on comparing blood-pool and myocardial T1 values before and after contrast administration, and anemia or hemoconcentration can bias the calculation. The partial survival of the FT3 association after these corrections lends cautious support to the idea that active thyroid hormone levels track with myocardial extracellular expansion, though larger prospective cohorts will be needed to confirm it.

Why does any of this matter beyond the imaging physics? Hyperthyroidism affects millions of people worldwide, most commonly women, and its cardiac complications — atrial fibrillation, heart failure, and increased mortality — are among the leading causes of excess risk in these patients. Yet the concept of hyperthyroid cardiomyopathy has hovered in a diagnostic gray zone: patients report palpitations, breathlessness, and fatigue; their ECGs show abnormalities; their biomarkers creep upward; but their echocardiograms and standard CMR assessments often look normal, and the label of a distinct thyroid-driven heart muscle disease has lacked objective tissue-level confirmation. Native T1 mapping now provides exactly that. A rise of roughly 30 milliseconds in unadjusted T1, and over 20 milliseconds after adjustment, may sound numerically modest, but in the world of T1 mapping such shifts are comparable to those seen in early diffuse fibrosis from other systemic diseases, and they occur before ejection fraction falls.

The study’s conclusions are measured but consequential: T1-mapping can detect myocardial tissue alterations among hyperthyroid patients with clinical suspicion of cardiac involvement. For clinicians, the implication is that multiparametric CMR — and native T1 mapping in particular — could become a valuable tool for identifying which hyperthyroid patients have genuine myocardial involvement, stratifying risk, and potentially monitoring whether tissue changes reverse as thyroid hormone levels are brought back under control. For researchers, the ECV-hormone correlations open a mechanistic thread worth pulling: if excess T3 drives extracellular matrix expansion in the myocardium, then early and aggressive hormonal control might prevent the progression from reversible tissue change to established fibrosis and heart failure. The study, approved by the institutional ethics review board of Shanghai General Hospital and supported by the National Natural Science Foundation of China and the Shanghai Municipal Commission of Education, is retrospective and modest in size, and its single-center design means the findings await replication. But as a proof of concept, it demonstrates that the heart of a hyperthyroid patient is not merely beating faster — it is quietly, measurably changing its composition, and for the first time medicine has a noninvasive way to see it.

Subject of Research: Myocardial tissue changes detected by multiparametric cardiac MRI in hyperthyroid patients with suspected cardiac involvement

Article Title: Myocardial tissue characteristics assessed by multiparametric CMR in hyperthyroid patients with suspected cardiac involvement

Article References: Myocardial tissue characteristics assessed by multiparametric CMR in hyperthyroid patients with suspected cardiac involvement. (n.d.). https://doi.org/10.1186/s12880-026-02807-0

Image Credits: AI Generated

DOI: 10.1186/s12880-026-02807-0

Keywords: hyperthyroidism, cardiac magnetic resonance, native T1 mapping, extracellular volume fraction, myocardial strain, thyroid hormone, cardiomyopathy, heart failure, triiodothyronine, BMC Medical Imaging, myocardial fibrosis, CMR imaging